Founding Partner Mölnlycke Health Care will move to GoCo in 2024

Mölnlycke Health Care stands for innovation and quality. This is also a strongly contributing reason why all Gothenburg-based operations within Mölnlycke will move to GoCo Health Innovation City at the end of 2024. »

The value of a Quality Target Product Profile in early development

Clinical trials make up a substantial portion of the overall drug development costs and pharmaceutical companies are intensely focused on ensuring that the trial is well designed and developed. The development of the actual drug product, the Chemistry, Manufacturing and Controls (CMC) section of Investigational Medicinal Products Dossiers (IMPDs) or Investigational New Drug (IND) applications, […] »

Faster access to new and more effective medicines

A long-term collaboration between AstraZeneca and Chalmers led to the founding of InSingulo in 2017. The core business is set up around the challenges of biophysics in drug discovery using single-molecule microscopy. »